Makio Ogawa to Growth Substances
This is a "connection" page, showing publications Makio Ogawa has written about Growth Substances.
Connection Strength
0.462
-
Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood. 1993 Feb 01; 81(3):610-6.
Score: 0.101
-
Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5. Leukemia. 1989 Jan; 3(1):14-8.
Score: 0.076
-
Erythroid burst-promoting activity of purified recombinant human GM-CSF and interleukin-3: studies with anti-GM-CSF and anti-IL-3 sera and studies in serum-free cultures. Blood. 1988 Oct; 72(4):1381-6.
Score: 0.075
-
Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages. Proc Natl Acad Sci U S A. 1988 Jun; 85(12):4360-4.
Score: 0.073
-
Interleukin 6 enhancement of interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci U S A. 1987 Dec; 84(24):9035-9.
Score: 0.071
-
Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. Blood. 2006 Nov 01; 108(9):2893-6.
Score: 0.064